Detalles de la búsqueda
1.
Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.
Oncologist
; 27(7): 525-531, 2022 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640145
2.
Incidence of immunotherapy-related hyperprogressive disease (HPD) across HPD definitions and cancer types in observational studies: A systematic review and meta-analysis.
Cancer Med
; 13(3): e6970, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38400685
3.
Cushing's Syndrome in Adenocarcinoma of Lung Responding to Osilodrostat.
Case Rep Oncol
; 16(1): 124-128, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36876215
4.
Role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes and toxicity in patients with cancer treated with immunotherapy.
J Immunother Cancer
; 10(3)2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347071
Resultados
1 -
4
de 4
1
Próxima >
>>